Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to 0.14%.

  • Krystal Biotech's Return on Capital Employed rose 600.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.15% for FY2025, which is 700.0% up from last year.
  • Krystal Biotech's Return on Capital Employed amounted to 0.14% in Q4 2025, which was up 600.0% from 0.14% recorded in Q3 2025.
  • Krystal Biotech's 5-year Return on Capital Employed high stood at 0.14% for Q3 2025, and its period low was 0.28% during Q1 2023.
  • Its 5-year average for Return on Capital Employed is 0.08%, with a median of 0.13% in 2021.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -1400bps in 2022, then surged by 2400bps in 2024.
  • Quarter analysis of 5 years shows Krystal Biotech's Return on Capital Employed stood at 0.13% in 2021, then plummeted by -103bps to 0.27% in 2022, then skyrocketed by 47bps to 0.14% in 2023, then skyrocketed by 150bps to 0.07% in 2024, then skyrocketed by 90bps to 0.14% in 2025.
  • Its Return on Capital Employed stands at 0.14% for Q4 2025, versus 0.14% for Q3 2025 and 0.14% for Q2 2025.